Company Overview and News

1
Why International Paper (IP) Could Beat Earnings Estimates Again

8h zacks
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider International Paper (IP - Free Report) . This company, which is in the Zacks Paper and Related Products industry, shows potential for another earnings beat.
IP INPAP

1
Sector ETF Week In Review For September 17-21

2018-09-23 seekingalpha
Just to set this week's column up, over the last few months, we've seen the sector performance take on a decidedly late-cycle orientation, with healthcare, utilities, and consumer staples outperforming other sectors. Let's see if that's still the case, shall we?
SHW IP PPG INPAP

25
The Zacks Analyst Blog Highlights: Caterpillar, International Paper, MetLife and Broadcom

2018-09-17 zacks
Chicago, IL – September 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Caterpillar Inc. (CAT - Free Report) , International Paper Company (IP - Free Report) , MetLife, Inc. (MET - Free Report) and Broadcom Limited (AVGO - Free Report) .
CAT MET FNMA FMCKI FMCKJ IP AVGO FMCCO FMCCP FMCCM CATR FMCCN INPAP FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCC BRCM FMCCS FMCCT

2
Should You Invest in the Invesco MSCI Global Timber ETF (CUT)?

2018-09-17 zacks
Looking for broad exposure to the Materials - Timber segment of the equity market? You should consider the Invesco MSCI Global Timber ETF (CUT - Free Report) , a passively managed exchange traded fund launched on 11/09/2007.
ARKG IP INPAP WRK

25
Lehman Brothers' Collapse: Did the Markets Learn Any Lesson?

2018-09-14 zacks
After surviving two world wars and 1930’s Great Depression, Lehman Brothers had filed for bankruptcy on Sep 15, 2008. The collapse of the leading investment bank not only affected its employees or investors but also led to a global financial crisis.
CY CAT MET FNMA FMCKI FMCKJ IP AVGO FMCCO FMCCP FMCCM CATR FMCCN INPAP FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCC BRCM FMCCS FMCCT

1
IP vs. SMFKY: Which Stock Is the Better Value Option?

2018-09-13 zacks
Investors interested in stocks from the Paper and Related Products sector have probably already heard of International Paper (IP - Free Report) and SMURFIT KAPPA (SMFKY - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
IP INPAP

1
International Paper - I'm Expecting A Bottom

2018-09-12 seekingalpha
The company expects healthy demand in the second half of this year along with lower outage costs.
IP INPAP

5
Packaging Corporation Of America: The Most Profitable Play In A No Moat, High-Growth Industry

2018-09-07 seekingalpha
In spite of the future growth prospects for the industry, Packing Corporation of America's valuation is reasonably cheap.
IP ODP INPAP MPSX WRK

2
Can International Paper Maintain Pricing Power?

2018-09-05 seekingalpha
I fear IP's pricing power will fade in the Industrial Packaging segment as more supply comes online.
IP INPAP WRK

1
International Paper Rides on Restructuring & Acquisitions

2018-09-04 zacks
Our experts cut down 220 Zacks Rank #1 Strong Buys to the 7 most likely to jump in price immediately.
CHTR IP

18
Wall Street Looks Stunning: A Bumpy Road Ahead?

2018-09-04 zacks
Although the domestic market looks stunning now with the Wall Street extending its marathon run and corporate profits consistently rising, are there threats ahead?
JBK DISH CATR GSC CAT INPAP TFG GSJ GS GLSSP AFL IP 8686 AFSD GJS

2
Why Oshkosh (OSK) is Such a Great Value Stock Pick Right Now

2018-08-31 zacks
Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends? Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Oshkosh Corporation (OSK - Free Report) . Oshkosh in Focus OSK may be an interesting play thanks to its forward PE of 11.
IP OSK SCVL INPAP BIG PAYC

9
Graphic Packaging Holding to Acquire Letica Foodservice in Q3

2018-08-29 zacks
Graphic Packaging Holding Company (GPK - Free Report) has announced yesterday that one of its completely-owned subsidiaries, Graphic Packaging International, LLC, signed an agreement to acquire Letica Corporation’s foodservice business (Letica Foodservice). The transaction value has been fixed at $95 million. Letica Foodservice primarily engages in the manufacturing of cold and hot cups from paperboard, and cartons.
RPCGF RPC RPCGY IP AIMC B INPAP URBN PBB PSEC GTLS

1
Why Jefferies (JEF) is Such a Great Value Stock Pick Right Now

2018-08-28 zacks
Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends? Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Jefferies Financial Group Inc. (JEF - Free Report) . Jefferies in Focus JEF may be an interesting play thanks to its forward PE of 12.
IP INPAP BGSF

1
IP vs. NP: Which Stock Should Value Investors Buy Now?

2018-08-27 zacks
Investors looking for stocks in the Paper and Related Products sector might want to consider either International Paper (IP - Free Report) or Neenah Paper (NP - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
IP INPAP NP

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to IP / International Paper Company on message board site Silicon Investor.

Wennerstrom Semi Equipment Analysis Wennerstrom Semi Equipment Analysis Wennerstrom Semi Equipment Analysis Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG
Home Theater Systems - Designs, Products, Tips and Info Home Theater Systems - Designs, Products, Tips and Info Home Theater Systems - Designs, Products, Tips and Info Priceline.com (PCLN)...another hot IPO ? Priceline.com (PCLN)...another hot IPO ? Priceline.com (PCLN)...another hot IPO ?
MCHP: Microchip Technology Inc. MCHP: Microchip Technology Inc. MCHP: Microchip Technology Inc. RedHat Linux distributor -- IPO RedHat Linux distributor -- IPO RedHat Linux distributor -- IPO
Got A Great Recipe To Share???? Got A Great Recipe To Share???? Got A Great Recipe To Share???? IPO and Other Stock Plays IPO and Other Stock Plays IPO and Other Stock Plays
Blank Check IPOs (SPACS) Blank Check IPOs (SPACS) Blank Check IPOs (SPACS) FBN Associates - Year 2000/Y2K IPO!!! FBN Associates - Year 2000/Y2K IPO!!! FBN Associates - Year 2000/Y2K IPO!!!
CUSIP: 460146103